Medidata Solutions Inc. (NASDAQ:MDSO) EVP Eileen Schloss sold 10,644 shares of the company’s stock in a transaction on Tuesday, July 26th. The stock was sold at an average price of $52.82, for a total transaction of $562,216.08. Following the transaction, the executive vice president now owns 25,765 shares of the company’s stock, valued at $1,360,907.30. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.
Several research analysts have recently issued reports on the stock. Wells Fargo & Co. downgraded shares of Medidata Solutions from an “outperform” rating to a “market perform” rating in a report on Thursday, July 21st. KeyCorp reiterated a “buy” rating and set a $55.00 price target on shares of Medidata Solutions in a report on Sunday, May 22nd. Jefferies Group downgraded shares of Medidata Solutions from a “hold” rating to an “underperform” rating and upped their price target for the stock from $35.00 to $36.00 in a report on Tuesday, April 26th. Leerink Swann assumed coverage on shares of Medidata Solutions in a report on Tuesday, April 26th. They set a “market perform” rating and a $47.00 price target for the company. Finally, Topeka Capital Markets reiterated a “buy” rating and set a $44.00 price target (up from $42.00) on shares of Medidata Solutions in a report on Tuesday, April 5th. One research analyst has rated the stock with a sell rating, three have issued a hold rating and eight have assigned a buy rating to the stock. The company currently has a consensus rating of “Buy” and an average target price of $51.70.
Shares of Medidata Solutions Inc. (NASDAQ:MDSO) traded up 0.34% during mid-day trading on Thursday, reaching $53.24. 283,847 shares of the company’s stock were exchanged. The company has a 50 day moving average price of $47.72 and a 200-day moving average price of $42.18. The stock has a market cap of $2.95 billion and a PE ratio of 136.86. Medidata Solutions Inc. has a one year low of $30.22 and a one year high of $54.99.
An institutional investor recently raised its position in Medidata Solutions stock. Rhumbline Advisers increased its position in Medidata Solutions Inc. (NASDAQ:MDSO) by 9.4% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 68,254 shares of the company’s stock after buying an additional 5,855 shares during the period. Rhumbline Advisers owned about 0.13% of Medidata Solutions worth $3,364,000 at the end of the most recent quarter.
Medidata Solutions Inc (Medidata) is a provider of cloud-based solutions for life sciences. The Company provides cloud-based solutions for clinical research in life sciences, offering platform technology that focuses on the clinical development. The Medidata Clinical Cloud provides a platform of technology and data analytics solutions designed to manage activities across clinical development.
